Imperial Valley News Center
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration today cleared for marketing the ENROUTE Transcarotid Neuroprotection System (ENROUTE TNS), for use during a minimally invasive procedure to restore normal blood flow to narrowed carotid arteries. It is the first device designed to access the carotid arteries through an incision in the neck, instead of the groin, and uses a blood flow reversal system to capture pieces of the blockage dislodged during the procedure.
- Written by John Grimaldi
Washington, DC - A growing number in Congress view AMAC's "Social Security Guarantee" solution as a long-term fix to the looming insolvency of the Old Age and Survivors Insurance (OASI) Trust Fund. The Association of Mature American Citizens (AMAC) is a 1.3-million-member senior organization established as the alternative to the liberal AARP.
- Written by State Department
Washington, DC - The United States today announced nearly $273 million in new humanitarian assistance for those uprooted and imperiled by the conflict in South Sudan. The additional funding was announced in Nairobi, Kenya by Assistant Secretary Anne C. Richard, U.S. Department of State Assistant Secretary for Population, Refugees, and Migration, at the “High-Level Event on the Humanitarian Crisis in South Sudan and its Impact in the Region.”
- Written by Emil Venere
West Lafayette, Indiana - A team of Purdue University researchers has been awarded a $1 million W.M. Keck Foundation grant to develop a new type of imaging technology for cell and tissue analysis.
- Written by POM v. FTC: A dozen quotable quotes from the D.C. Circuit opinion
Washington, DC - POM Wonderful’s advertising claims were false and deceptive. That’s the conclusion of the United States Court of Appeals in upholding the FTC’s ruling. We think it’s a momentous victory for our two clients: American consumers and the cause of truth in the marketplace. You’ll want to read the entire opinion, of course, but here are twelve quotes from the D.C. Circuit’s decision that businesses, attorneys, and law enforcers will be citing for years to come.
- Written by Scott LaFee
San Diego, California - Seeking to boldly go where medical science has not gone before, the Clinical and Translational Research Institute (CTRI) at the University of California, San Diego has been named the official testing site for the $10 million Qualcomm Tricorder XPRIZE, a global competition sponsored by the Qualcomm Foundation to develop a consumer-friendly, mobile device capable of diagnosing and interpreting 15 physiological conditions and capturing vital health metrics.
Page 2047 of 2293